References
- Rush AJ, Trivedi MH, Wisniewski SR, et al., Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 163(11): 1905–1917. 2006.
- Khunger M, Jain P, Rakshit S, et al., Safety and efficacy of PD-1/PD-L1 inhibitors in treatment-naive and chemotherapy-refractory patients with non-small-cell lung cancer: a systematic review and meta-analysis. Clin Lung Cancer. 19(3): e335–48. 2018.
- Singh S, Fumery M, Sandborn WJ, et al., Systematic review and network meta-analysis: first- and second-line biologic therapies for moderate-severe Crohn’s disease. Aliment Pharmacol Ther. 48(4): 394–399. 2018.
- Vallejo-Torres L, Castilla I, Gonzalez N, et al. Cost-effectiveness of electroconvulsive therapy compared to repetitive transcranial magnetic stimulation for treatment-resistant severe depression: a decision model. Psychol Med. 2015;45(7):1459–1470.
- Iqbal A, Jan A, Wajid MA, et al. Management of chronic non-healing wounds by hirudotherapy. World J Plast Surg. 2017;6(1):9–17.
- Acelajado MC, Hughes ZH, Oparil S, et al. Treatment of resistant and refractory hypertension. Circ Res. 2019;124(7):1061–1070.
- Dendukuri N, Joseph L. Bayesian approaches to modeling the conditional dependence between multiple diagnostic tests. Biometrics. 2001;57(1):158–167.
- Wang Z, Dendukuri N, Zar HJ, et al., Modeling conditional dependence among multiple diagnostic tests. Stat Med. 36(30): 4843–4859. 2017.
- Wang Z, Dendukuri N, Joseph L. Understanding the effects of conditional dependence in research studies involving imperfect diagnostic tests. Stat Med. 2017;36(3):466–480.
- Gut A. An intermediate course in probability. 2nd ed. Springer-Verlag New York; 2009.
- Wicklin R. Simulating data with SAS. Cary NC: SAS Institute Inc; 2013.
- Griesinger F, Korol EE, Kayaniyil S, et al. Efficacy and safety of first-line carboplatin-versus cisplatin-based chemotherapy for non-small cell lung cancer: a meta-analysis. Lung Cancer. 2019;135:196–204.
- Blumberger DM, Mulsant BH, Emeremni C, et al. Impact of prior pharmacotherapy on remission of psychotic depression in a randomized controlled trial. J Psychiatr Res. 2011;45(7):896–901.
- Hsu JH, Mulsant BH, Lenze EJ, et al. Impact of prior treatment on remission of late-life depression with venlafaxine and subsequent aripiprazole or placebo augmentation. Am J Geriatr Psychiatry. 2016;24(10):918–922.
- Prudic J, Haskett RF, Mulsant B, et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry. 1996;153:985–992.
- Papakostas GI, Fava M, Thase ME. Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches. Biol Psychiatry. 2008;63(7):699–704.
- Li M, Yao X, Sun L, et al. Effects of electroconvulsive therapy on depression and its potential mechanism. Front Psychol. 2020;11:80.
- Leiknes KA, Jarosh-von Schweder L, Hoie B. Contemporary use and practice of electroconvulsive therapy worldwide. Brain Behav. 2012;2(3):283–344.
- Fitzgibbon KP, Plett D, Chan BCF, et al. Cost-utility analysis of electroconvulsive therapy and repetitive transcranial magnetic stimulation for treatment-resistant depression in ontario. Can J Psychiatry. 2020;65(3):164–173.
- Kozel FA, George MS, Simpson KN. Decision analysis of the cost-effectiveness of repetitive transcranial magnetic stimulation versus electroconvulsive therapy for treatment of nonpsychotic severe depression. CNS Spectr. 2004;9(6):476–482.
- Haq AU, Sitzmann AF, Goldman ML, et al. Response of depression to electroconvulsive therapy: a meta-analysis of clinical predictors. J Clin Psychiatry. 2015;76(10):1374–1384.